Literature DB >> 12399781

Infliximab for the treatment of severe pustular psoriasis.

Boni E Elewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12399781     DOI： 10.1067/mjd.2002.128382

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.

Authors:  Andrew Johnston; Xianying Xing; Liza Wolterink; Drew H Barnes; ZhiQiang Yin; Laura Reingold; J Michelle Kahlenberg; Paul W Harms; Johann E Gudjonsson
Journal:  J Allergy Clin Immunol       Date:  2016-12-31       Impact factor: 10.793

2.  A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

Authors:  Bruce E Strober; Jennifer Clay Cather; David Cohen; Jeffrey J Crowley; Kenneth B Gordon; Alice B Gottlieb; Arthur F Kavanaugh; Neil J Korman; Gerald G Krueger; Craig L Leonardi; Sergio Schwartzman; Jeffrey M Sobell; Gary E Solomon; Melodie Young
Journal:  Dermatol Ther (Heidelb)       Date:  2012-03-30

3.  Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports.

Authors:  Jiajing Lu; Ying Li; Ning Yu; Fujuan Chen; Yangfeng Ding; Xuemei Yi
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.